Business Description
Evolent Health Inc
NAICS : 621999
SIC : 8099
ISIN : US30050B1017
Description
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's two reportable segments: EHS and Clinical Solutions. The Company's EHS segment provides an integrated administrative and clinical platform for health plan administration and value-based business infrastructure and clinical Solutions segment addresses a broad spectrum of clinical needs, with tailored solutions for specialty care management in oncology and cardiology and increasingly the musculoskeletal markets and holistic total cost of care improvement. It generates a majority of its revenue from Clinical Solutions segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.64 | |||||
| Debt-to-EBITDA | -17.33 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.28 | |||||
| Beneish M-Score | -0.95 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 20 | |||||
| 3-Year EPS without NRI Growth Rate | 62.1 | |||||
| 3-Year FCF Growth Rate | 17.5 | |||||
| 3-Year Book Growth Rate | -7.6 | |||||
| Future 3-5Y Total Revenue Growth Rate | 14.78 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.84 | |||||
| 9-Day RSI | 59.26 | |||||
| 14-Day RSI | 53.36 | |||||
| 6-1 Month Momentum % | -16.86 | |||||
| 12-1 Month Momentum % | -26.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.07 | |||||
| Quick Ratio | 1.07 | |||||
| Cash Ratio | 0.26 | |||||
| Days Sales Outstanding | 52.29 | |||||
| Days Payable | 20.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.7 | |||||
| Shareholder Yield % | -7.77 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.72 | |||||
| Operating Margin % | -1.62 | |||||
| Net Margin % | -3.89 | |||||
| ROE % | -6.74 | |||||
| ROA % | -3.14 | |||||
| ROIC % | -0.53 | |||||
| ROC (Joel Greenblatt) % | -103.43 | |||||
| ROCE % | -8.7 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 42.26 | |||||
| PS Ratio | 1.68 | |||||
| PB Ratio | 2.75 | |||||
| Price-to-Operating-Cash-Flow | 103.85 | |||||
| EV-to-EBIT | -25.96 | |||||
| EV-to-Forward-EBIT | 15.62 | |||||
| EV-to-EBITDA | -89.57 | |||||
| EV-to-Forward-EBITDA | 16.05 | |||||
| EV-to-Revenue | 2.19 | |||||
| EV-to-Forward-Revenue | 1.47 | |||||
| EV-to-FCF | -306.28 | |||||
| Price-to-Projected-FCF | 9.87 | |||||
| Earnings Yield (Greenblatt) % | -3.85 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:EVH
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Evolent Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,631.843 | ||
| EPS (TTM) ($) | -0.7 | ||
| Beta | 0.88 | ||
| Volatility % | 38.08 | ||
| 14-Day RSI | 53.36 | ||
| 14-Day ATR ($) | 0.727407 | ||
| 20-Day SMA ($) | 26.109 | ||
| 12-1 Month Momentum % | -26.32 | ||
| 52-Week Range ($) | 21.8322 - 37.9799 | ||
| Shares Outstanding (Mil) | 113.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Evolent Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Evolent Health Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Evolent Health Inc Frequently Asked Questions
What is Evolent Health Inc(EVH)'s stock price today?
The current price of EVH is $26.75. The 52 week high of EVH is $37.98 and 52 week low is $21.83.
When is next earnings date of Evolent Health Inc(EVH)?
The next earnings date of Evolent Health Inc(EVH) is 2023-11-02 Est..
Does Evolent Health Inc(EVH) pay dividends? If so, how much?
Evolent Health Inc(EVH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers